Abstract
The natural compound tyropeptin A, a new peptidyl aldehyde proteasome inhibitor, was
tested for its trypanocidal activity in vitro using culture-adapted bloodstream forms of Trypanosoma brucei. The concentrations of tyropeptin A required to reduce the growth rate by 50 % and
to kill all cells were 10 and 100 times lower for bloodstream-form trypanosomes than
for human leukaemia HL-60 cells, respectively. Enzymatic analysis showed that the
trypsin-like activity of the trypanosome proteasome and the chymotrypsin-like activity
of the mammalian proteasome are particularly sensitive to inhibition by tyropeptin
A. The results suggest that natural compounds targeting the trypsin-like activity
of the proteasome may serve as leads for rational drug development of novel anti-trypanosomal
agents.
References
- 1
Barrett M P, Burchmore R J, Stich A, Lazzari J O, Frasch A C, Cazzulo J J. et al
.
The trypanosomaises.
Lancet.
2003;
362
1469-80
- 2
Fairlamb A H.
Chemotherapy of human African trypanosomiasis: current and future prospects.
Trends Parasitol.
2003;
19
488-94
- 3
Matovu E, Seebeck T, Enyaru J CK, Kaminsky R.
Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.
Microbes Infect.
2001;
3
763-70
- 4
Hoet S, Opperdoes F, Brun R, Quetin-Leclercq J.
Natural products active against African trypanosomes: a step towards new drugs.
Nat Prod Rep.
2004;
21
353-64
- 5
Nkemgu-Njinkeng J, Rosenkranz V, Wink M, Steverding D.
Antitrypanosomal activities of proteasome inhibitors.
Antimicrob Agents Chemother.
2002;
46
2038-40
- 6
Glenn R J, Pemberton A J, Royle H J, Spackman R W, Smith E, Rivett A J. et al .
Trypanocidal effect of α′,β′-epoxyketones indicates that trypanosomes are particularly
sensitive to inhibitors of proteasome trypsin-like activity.
Int J Antimicrob Agents.
2004;
24
286-9
- 7
Momose I, Sekizawa R, Hashizume H, Kinoshita N, Homma Y, Hamada M. et al .
Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK933-dF2. 1. Taxonomy, isolation, physio-chemical properties and biological
activities.
J Antibiot (Tokyo).
2001;
54
997-1003
- 8
Scory S, Steverding D.
Differential toxicity of ricin and diphtheria toxin for bloodstream forms of Trypanosoma brucei
.
Mol Biochem Parasitol.
1997;
90
289-95
- 9
Scory S, Caffrey C R, Stierhof Y D, Ruppel A, Steverding D.
Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-Phe-Ala-CHN2
.
Exp Parasitol.
1999;
91
327-33
- 10
Steverding D, Stierhof Y D, Fuchs H, Tauber R, Overath P.
Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei
.
J Cell Biol.
1995;
131
1173-82
- 11
Kabiri M, Steverding D.
Trypanosoma evansi: demonstration of a transferrin receptor derived from expression site-associated
genes 6 and 7.
J Parasitol.
2001;
87
1189-91
- 12
Steverding D, Spackman R W, Royle H J, Glenn R J.
Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors.
Parasitol Res.
2005;
95
73-6
- 13
Hua S B, To W Y, Nguyen T T, Wong M L, Wang C C.
Purification and characterization of proteasomes from Trypanosoma brucei
.
Mol Biochem Parasitol.
1996;
78
33-46
- 14
Wang C C, Bozdech Z, Liu C L, Shipway A, Backes B J, Harris J L. et al .
Biochemical analysis of the 20S proteasome of Trypanosoma brucei
.
J Biol Chem.
2002;
278
15 800-8
- 15
Merschjohann K, Sporer F, Steverding D, Wink M.
In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense
.
Planta Med.
2001;
67
623-7
- 16
Hirumi H, Hirumi K, Doyle J J, Cross G AM.
In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei
.
Parasitology.
1980;
80
371-82
- 17
Collins S R, Gallo R C, Gallagher R E.
Continuous growth and differentiation of human myeloid leukaemic cells in suspension
cultures.
Nature.
1997;
270
347-9
- 18
Baltz T, Baltz D, Giroud C, Crockett J.
Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense
.
EMBO J.
1985;
4
1273-7
- 19
Huber W, Koella J C.
A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites.
Acta Trop.
1993;
55
257-61
- 20
Rivett A J, Savory P J, Djaballah H.
Multicatalytic endopeptidase complex: proteasome.
Methods Enzymol.
1994;
244
331-50
Priv.-Doz. Dr. Dietmar Steverding
School of Medicine, Health Policy and Practice
University of East Anglia
Norwich NR4 7TJ
United Kingdom
Fax: +44-1603-59-3752
eMail: dsteverding@hotmail.com